- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
Papers: 21 Nov 2020 - 27 Nov 2020
Human Studies, Pharmacology/Drug Development
PAIN TYPE:
Migraine/Headache
2020 Oct 05
Pediatr Neurol
114
Monoclonal antibodies to calcitonin gene-related peptide or its receptor have clinical trial evidence in adults with headache, but data are lacking in adolescents. The objective of this study was to describe the safety and efficacy of calcitonin gene-related peptide monoclonal antibody treatment in adolescents with chronic headache disorders.